Millions of statin-treated Americans are using unproven or outdated treatment choices in an effort to protect their hearts. Cardiovascular disease is the number one
Cardiovascular disease is the number one cause of death for men and women in the United States, accounting for 1 of every 3 deaths.
Statins are the first-line prescription therapy to reduce the risk for cardiovascular events, such as heart attack and stroke, but they only lower the risk of a life-threatening cardiovascular event by 25-35%, which is why many patients turn to or are prescribed additional treatments to further reduce cardiovascular risk. New consumer and physician survey data revealed that patients are often prescribed or recommended fenofibrates, niacin, or dietary fish oil supplements on top of statins to treat their persistent cardiovascular risk. Many healthcare professionals were unaware that fenofibrates and niacin, when used with statins, are not FDA-approved, when in fact, the FDA withdrew approval for fenofibrates and niacin in combination with statins because the risk outweighed the benefit. Additionally, many patients admitted they do not regularly investigate cardiovascular disease treatments beyond what their doctor shares with them, and specifically, those taking fenofibrates believe they are doing everything they can to prevent future cardiovascular events.
So what should you do? Click here for more information.
